Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Predictive Oncology stock
Learn how to easily invest in Predictive Oncology stock.
Predictive Oncology is a medical instruments & supplies business based in the US. Predictive Oncology shares (POAI) are listed on the NASDAQ and all prices are listed in US Dollars. Predictive Oncology employs 30 staff and has a trailing 12-month revenue of around $1.6 million.
How to buy Predictive Oncology stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – POAI. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Easy to use platform with low fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
Predictive Oncology stock price (NASDAQ: POAI)Use our graph to track the performance of POAI stocks over time.
Predictive Oncology shares at a glance
|Latest market close||$0.61|
|52-week range||$0.21 - $1.10|
|50-day moving average||$0.40|
|200-day moving average||$0.42|
|Wall St. target price||$5.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.31|
Buy Predictive Oncology stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Predictive Oncology stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Predictive Oncology price performance over time
|1 week (2023-01-31)||14.53%|
|1 month (2023-01-06)||64.50%|
|3 months (2022-11-08)||144.76%|
|6 months (2022-08-08)||29.42%|
|1 year (2022-02-08)||-24.69%|
|2 years (2021-02-08)||-61.82%|
|3 years (2020-02-07)||2.41|
|5 years (2018-02-07)||11.055|
Predictive Oncology financials
|Revenue TTM||$1.6 million|
|Gross profit TTM||$933,656|
|Return on assets TTM||-22.6%|
|Return on equity TTM||-66.11%|
|Market capitalisation||$42.1 million|
TTM: trailing 12 months
Predictive Oncology share dividends
We're not expecting Predictive Oncology to pay a dividend over the next 12 months.
Have Predictive Oncology's shares ever split?
Predictive Oncology's shares were split on a 1:10 basis on 28 October 2019. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Predictive Oncology shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Predictive Oncology shares which in turn could have impacted Predictive Oncology's share price.
Predictive Oncology share price volatility
Over the last 12 months, Predictive Oncology's shares have ranged in value from as little as $0.21 up to $1.1. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Predictive Oncology's is 1.2033. This would suggest that Predictive Oncology's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Predictive Oncology overview
Predictive Oncology Inc. , a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract research services through patient-centric drug discovery using active learning technology for discovery, clinical and translational research, clinical trials, and diagnostic development and validation. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using High-Throughput Self-Interaction Chromatography, a self-contained, automated system that conducts high-throughput, self-interaction chromatography screens using additives and excipients that are included in protein formulations for soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal.
Predictive Oncology in the news
Predictive Oncology Appoints Pamela Bush, Ph.D., MBA, as Chief Business Officer
Pioneer of Computational Biology Joins the Scientific Advisory Board of Predictive Oncology
7 Artificial Intelligence Stocks Under $10 for Your 2023 Watch List
Frequently asked questionsWhat percentage of Predictive Oncology is owned by insiders or institutions?
Currently 4.926% of Predictive Oncology shares are held by insiders and 5.702% by institutions. How many people work for Predictive Oncology?
Latest data suggests 30 work at Predictive Oncology. When does the fiscal year end for Predictive Oncology?
Predictive Oncology's fiscal year ends in December. Where is Predictive Oncology based?
Predictive Oncology's address is: 2915 Commers Drive, Eagan, MN, United States, 55121 What is Predictive Oncology's ISIN number?
Predictive Oncology's international securities identification number is: US74039M2008 What is Predictive Oncology's CUSIP number?
Predictive Oncology's Committee on Uniform Securities Identification Procedures number is: 09071P109
More guides on Finder
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Ask an Expert